Hydroxyzine
| Hydroxyzine | |
|---|---|
| Salts [] | |
|---|---|
| Hydroxyzine dihydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 374.90 g/mol [1] |
| Appearance | Oil [1] |
| Melting point | 200C [1] |
| Boiling point | 220 °C at 0.5 mm Hg [1] |
| Solubility | Crystals; MP 193 °C; Bitter taste. Solubility in mg/mL: water <700; chloroform 60; acetone 2; ether <0.1. Solutions are unstable to intense UV light. /Hydroxyzine dihydrochloride/ [1] |
| Predicted LogP | 3.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C21H27ClN2O2 |
| IUPAC name | 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol |
| SMILES | C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl |
| InChI | InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2 |
| InChIKey | ZQDWXGKKHFNSQK-UHFFFAOYSA-N |
| CAS number | 68-88-2 |
| UNII | 30S50YM8OG |
| PubChem CID | 3658 |
| Pharmacokinetics[] | |
|---|---|
| Metabolism | Liver by CYP3A4 and CYP3A5 |
| Excretion | Urine, feces |
| Routes of administration | By mouth, intramuscular |
| Dependence liability | Very low[3] |
| Addiction liability | None-very low |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - oral: 480 mg/kg Rat: - oral: 840 mg/kg - ip: 160 mg/kg - iv: 45 mg/kg [1] |
Hydroxyzine (also known as Hydroxizine, Hydroxyzin, Hydroxycine, Hydroxine, Hydroxizinum, Tranquizine, Ataraxoid, Hychotine, Tran-Q or Atarazoid) is a substance of the 1-benzylpiperazine and α-alkylbenzylamine class.
Chemistry
Salts []
Stereochemistry []
Hydroxyzine is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Hydroxyzine matches Lipinski's rule of five.Reagents
There are currently 1 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change |
Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- anxiolytics (N05B)
- diphenylmethane derivatives (N05BB)
- (N05BB01)
- hydroxyzine (N05BB01)
MeSH Classification
Mechanism of action []
The H<sub>1</sub> histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to an allergen results in degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H<sub>1</sub> receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Hydroxyzine is a potent inverse agonist of histamine H<sub>1</sub>-receptors - inverse agonists are agents that are considered to have a "negative efficacy", so rather than simply blocking activity at a receptor they actively dampen its activity. Inverse agonism at these receptors is responsible for hydroxyzine's efficacy in the treatment of histaminic edema, flare, and pruritus. Hydroxyzine is not a cortical depressant, so its sedative properties likely occur at the subcortical level of the CNS. These sedative properties allow activity as an anxiolytic. Antiemetic efficacy is likely secondary to activity at off-targets. [1]
Interactions []
Medical side effects []
14 side effects listed on drug labels in SIDER 4.1 (hydroxyzine).
- Somnolence
- Dermatitis
- Rash
- Hallucination
- Headache
- Hypersensitivity
- Hypotension
- Convulsion
- Tremor
- Urticaria
- Dry mouth
- Stupor
- Depressed level of consciousness
- Drug eruption
Indications
- Agitation
- Alcoholism
- Allergic conditions
- Anxiety
- Apprehension
- Asthma
- Cardiac disorder
- Delirium tremens
- Emotional problems
- Nausea
- Neurosis
- Pruritus
- Psychotic disorder
- Skin disorder
- Tension
- Urticaria chronic
- Vomiting
- Vomiting in pregnancy
- Withdrawal symptom
Subjective effects []
| nervewing / Hydroxyzine [] | |
|---|---|
| Pilz / Hydroxyzine [] | |
|---|---|
Routes:
| |
| x86pup / Hydroxyzine [] | |
|---|---|
Routes:
| |
Experience reports
Erowid
There are currently 12 experience reports involving hydroxyzine on Erowid: []- "Great Relaxer & Warmth" by aura
- "Physical Effects Increased, Not Mental Effects" by heyheyheihei
- "Visit From the Aether" by nervewing
- "Antihistamine Autism Adjustment" by Autistic Cannabistic
- "Selegiline Awakens the Middle Aged" by ShadowsDancing
- "Not Worth the Side Effects" by nova
- "Not Recreational but Not Useles" by godzillaman
- "It Doesn't Do Anything" by Rocket
- "Did Fuck-All Nothing for Anxiety" by zerotriad
- "Good for Anxiety" by Anonymous
- "Beating the Crash in the Philippines" by psychAJelic
- "Had Me All of Where I Wanted to Be" by Questor
- "A terrible LSA trip" by blackdeath8404 (16 upvotes)
- "Weed + DPH + DXM + Codeine + Benzedrex + Hydroxyzine" by AdministrationMany53 (11 upvotes)
- "What was in that gummy? A "cannabis oil" trip report" by nils_olav_III (4 upvotes)
- "Edibles scared me. Please help." by Key_Ad_7766 (2 upvotes)
- "What was in that gummy? Re-written by ChatGPT in the style of a Terrence McKenna trip report" by nils_olav_III (1 upvotes)
Legal status []
- Australia: Hydroxyzine is a Schedule 4.
- Canada: Hydroxyzine is Prescription only.
- European Union: Hydroxyzine is Prescription only.
- United Kingdom: Hydroxyzine is Prescription only.
- United States: Hydroxyzine is Prescription only.
- Other: Hydroxyzine is a SE: Rx-only.
External links []
- Hydroxyzine (Wikipedia)
- Hydroxyzine (PubChem)
- Hydroxyzine (Wikidata)
- Hydroxyzine (DrugBank)
- Hydroxyzine (ChEMBL)
- Hydroxyzine (ChEBI)
- Hydroxyzine (Common Chemistry)
- Hydroxyzine (HMDB)
- Hydroxyzine (KEGG)
- Hydroxyzine (EPA DSSTox)
- Hydroxyzine (Effect Index)
- Hydroxyzine (UNII)
- Hydroxyzine (SIDER)
- Hydroxyzine (Erowid)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3658, Hydroxyzine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3658
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Hydroxyzine. UNII: 30S50YM8OG. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/30S50YM8OG
Comparing Hydroxyzine vs Xanax for Anxiety. Carolina Center for Recovery. https://carolinacenterforrecovery.com/addiction-blog/what-is-the-difference-between-hydroxyzine-and-xanax/
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 06:02:56 |
| drugspro | ok | 2026-11-20 06:02:52 |
| erowid | ok | 2026-11-20 06:02:59 |
| gsrs | ok | 2026-11-20 06:02:53 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014697) | 2026-11-20 06:02:52 |
| kegg | ok | 2026-11-20 06:02:55 |
| pubchem | ok | 2026-11-20 06:02:51 |
| ok | 2026-11-20 06:02:52 | |
| sider | ok | 2026-11-20 06:02:52 |
| structure | ok | 2026-11-20 06:02:52 |
| wikipedia | ok | 2026-11-20 06:02:52 |